Kazuto Ikemoto | Industrial Engineering | Best Researcher Award

Published on by Popular Engineer

Dr. Kazuto Ikemoto | Industrial Engineering | Best Researcher Award

Mitsubishi Gas Chemical Company | Japan

Dr. Kazuto Ikemoto is a Senior Scientist at the Niigata Research Laboratory of Mitsubishi Gas Chemical Company, Inc., specializing in chemistry, food functionality, biotechnology, and semiconductor cleaning. He earned his Ph.D. in Chemistry from Nagasaki University, Japan, in 1995. Since then, he has been with Mitsubishi Gas Chemical Company, Inc., contributing significantly to research in his areas of expertise. Dr. Ikemoto’s research interests focus on the development and application of pyrroloquinoline quinone (PQQ) in various biological and health-related contexts. His work includes exploring PQQ’s effects on brain function, aging, obesity, and its potential antiviral properties , he was honored with the JSBBA Award for Corporate Researchers, recognizing his contributions to the field. Dr. Ikemoto’s research has been published in several peer-reviewed journals, reflecting his ongoing commitment to advancing scientific knowledge in his areas of expertise.

Profile : Scopus

Featured Publications

Discovery and application of food catalysts to promote the coupling of PQQ (quinone) with amines. Frontiers in Nutrition  (2024).

The effects of pyrroloquinoline quinone disodium salt on brain function and physiological processes. Frontiers in Nutrition. [Review, open access] (2024).

World Health Organization. (2025). World health statistics 2025: Monitoring health for the SDGs, Sustainable Development Goals. Geneva, Switzerland: World Health Organization.

United Nations Department of Economic and Social Affairs, Population Division. (2024). World population prospects 2024: Summary of results (UN DESA/POP/2024/TR/NO. 9). New York, NY, USA: United Nations.

López-Otín, C., Blasco, M. A., Partridge, L., Serrano, M., & Kroemer, G. (2013). The hallmarks of aging. Cell, 153(6), 1194–1217.

Ehsan Khedre | Biology and Life Sciences | Best Researcher Award

Published on by Popular Engineer

Dr. Ehsan Khedre | Biology and Life Sciences | Best Researcher Award

Egyptian Drug Authority Pyramids Branch | Egypt

Dr. Ehsan Khedre is a pharmaceutical biochemistry researcher whose work spans natural product pharmacology, nanotechnology, oxidative stress, and metabolic disease. After earning her B.Pharm (Ain-Shams University, Egypt, 2004), she completed an M.Sc. in Biochemistry (Zagazig University, 2011) and a Ph.D. (Al-Azhar University, 2018) on estrogenic effects of quercetin and its nanoparticles. She has held roles at Egypt’s National Organization for Drug Control & Research (NODCAR / EDA), advancing from drug control specialist to quality manager and researcher in biochemical laboratories. Her publication record (to date > 9 peer-reviewed articles) includes studies on hepatic fibrosis, nanocarrier enhancement of phytochemicals, metabolic syndrome models, and nanoparticle biodistribution. Her citation metrics h-index of 5, total documents 7, total citations 170 reflect her growing impact in pharmacology and toxicology. Her research interests include antioxidant and anti-inflammatory natural compounds, nanoparticle delivery systems, biochemical mechanisms of organ injury, and translational approaches to metabolic and hepatic diseases. She has also contributed by serving as reviewer for journals, receiving training in quality systems (ISO 9001 / ISO 17025), scientific writing, bioinformatics, and innovation, and participating in workshops on research skills. In sum, Dr. Khedre combines deep domain expertise, laboratory leadership, and interdisciplinary scholarship to advance discovery and application of therapeutics.

Profiles : Orcid | Scopus

Featured Publications

Fayed, E. A., El-Sebaey, S. A., Ebrahim, M. A., Abu-Elfotuh, K., El-Sayed Mansour, R., Mohamed, E. K., Hamdan, A. M. E., Al-subaie, F. T., Albalawi, G. S., Albalawi, T. M., et al. (2025). Discovery of novel bicyclic and tricyclic cyclohepta[b]thiophene derivatives as multipotent AChE and BChE inhibitors, in-vivo and in-vitro assays, ADMET and molecular docking simulation. European Journal of Medicinal Chemistry, 117201.

Abu-Elfotuh, K., Kamel, G. A. M., Najm, M. A. A., Hamdan, A. M. E., Koullah, M. T., Fahmy, R. K. E., Aboelsoud, H. A., Alghusn, M. A., Albalawi, B. R., Atwa, A. M., et al. (2025). Modulating multiple molecular trajectories by nutraceuticals and/or physical activity in attention-deficit/hyperactivity disorder (ADHD)-like behaviors in rat pups. Journal of NeuroImmune Pharmacology.

Oudah, K. H., Najm, M. A. A., Ramsis, T. M., Ebrahim, M. A., Gohar, N. A., Abu-Elfotuh, K., Mohamed, E. K., Hamdan, A. M. E., Hamdan, A. M., Almotairi, R., et al. (2025). Unlocking therapeutic potential of novel thieno-oxazepine hybrids as multi-target inhibitors of AChE/BChE and evaluation against Alzheimer’s disease: In vivo, in vitro, histopathological, and docking studies. Pharmaceuticals, 18(8), 1214.

Nazeam, J. A., Black, I., Mulamoottil, V. A., Selim, N. M., El Shiekh, R. A., Abu-Elfotuh, K., Hamdan, A. M. E., Gowifel, A. M. H., Hafez, S. M., Mohamed, E. K., et al. (2025). Okra seed polysaccharides mitigate neuroinflammation and cognitive impairment via modulation of Nrf2/HO-1, HMGB1/RAGE/TLR4/NF-κB, NLRP3/Caspase-1, JAK-2/STAT-3, AMPK/SIRT1/m-TOR, PI3K/AKT/CREB/BDNF/TrkB and PERK/CHOP/Bcl-2 axes. International Immunopharmacology, 114110.

Mohamed, E. K., Fathy, M. M., Sadek, N. A., & Eldosoki, D. E. (2024). The effects of rutin coat on the biodistribution and toxicities of iron oxide nanoparticles in rats. Journal of Nanoparticle Research, 26(3), 49.

Yan Ding | Biology and Life Sciences | Excellence in Research

Published on by Popular Engineer

Prof. Yan Ding | Biology and Life Sciences | Excellence in Research

China Medical University | China

Dr. Yan Ding is a biomedical researcher with a doctorate from China Medical University, Shenyang. Her academic training includes a Bachelor’s degree from Shenyang Pharmaceutical University, a Master’s and PhD from China Medical University. Since 2013, she has progressed through roles in experimental research—assistant experimentalist, experimentalist, and since 2022, senior experimentalist—at the Institute of Metabolic Disease Research & Drug Development and the College of Basic Medical Science. Her research focuses on molecular and cellular mechanisms underlying lung injury, inflammation, epithelial sodium transport, miRNA regulation, pulmonary fibrosis and herbal / natural compounds’ effects. She has published numerous first-author papers addressing roles of miRNAs (e.g. miR-130a-3p, miR-199a-3p, miR-21), luteolin’s therapeutic potential, regulation of epithelial sodium channel (ENaC), anti-oxidant and anti-inflammatory pathways. she has an h-index of 6 with 143 citations overall. Throughout her career, she has also contributed to studies of lung fluid clearance, regulatory mechanisms during viral infections, and herbal monomers in edematous disorders. Awards include recognition for excellence in experimental work (institutional). In conclusion, Dr. Ding is an emerging researcher building a solid track record in pulmonary molecular biology, with demonstrated expertise in miRNAs, ion channel regulation, and translational potential in lung disease therapy.

Profile : Google scholar

Featured Publications

“Factors influencing the provision of public health services by village doctors in   Hubei and Jiangxi provinces,
China”

“Practical actions for fostering cross-disciplinary global health research: lessons from a narrative literature         review”

“Healthcare seeking behaviour among Chinese elderly”

“A cost-effectiveness analysis of three components of a syndromic surveillance system for the early warning of   epidemics in rural China”

“Qualitative study exploring lessons from Liberia and the UK for building a people-centred resilient health system response to COVID-19”